AccueilGroupesDiscussionsPlusTendances
Site de recherche
Ce site utilise des cookies pour fournir nos services, optimiser les performances, pour les analyses, et (si vous n'êtes pas connecté) pour les publicités. En utilisant Librarything, vous reconnaissez avoir lu et compris nos conditions générales d'utilisation et de services. Votre utilisation du site et de ses services vaut acceptation de ces conditions et termes.

Résultats trouvés sur Google Books

Cliquer sur une vignette pour aller sur Google Books.

Chargement...

The Golden Helix: Inside Biotech Ventures

par Arthur Kornberg

MembresCritiquesPopularitéÉvaluation moyenneDiscussions
22Aucun1,057,234 (2.83)Aucun
The average person - indeed, even the relatively sophisticated reader - is at once dazzled and mystified by the facts of biotechnology, both as a business and as an intellectual enterprise. Now Arthur Kornberg, drawing extensively on his own experiences in biotech ventures, elucidates much about this most exciting of human undertakings. In The Golden Helix, he provides an insider's view of biotechnology - an inherently fascinating confluence of science and industry made possible, in large measure, by his epoch-making work with enzymes and DNA, for which he was awarded a Nobel Prize. Although science is at the center of this story, its principal subject is people - not only research scientists but business executives and managers as well. One of the most prominent and impressive figures in the story is Alejandro Zaffaroni, a remarkably successful and charismatic scientist-entrepreneur, whose vision and enthusiasm were instrumental in the founding of the DNAX Institute of Molecular and Cellular Biology, Inc. Another remarkable character in this story is Robert P. Luciano, CEO of the Schering-Plough Corporation, the pharmaceutical company that acquired DNAX a little more than a year after its founding. Although the history of DNAX is presented here in the greatest detail, various other prominent biotech ventures are profiled as well, including, most notably, ALZA, Genentech, Amgen, Chiron, and Regeneron.… (plus d'informations)
Aucun
Chargement...

Inscrivez-vous à LibraryThing pour découvrir si vous aimerez ce livre

Actuellement, il n'y a pas de discussions au sujet de ce livre.

Aucune critique
aucune critique | ajouter une critique
Vous devez vous identifier pour modifier le Partage des connaissances.
Pour plus d'aide, voir la page Aide sur le Partage des connaissances [en anglais].
Titre canonique
Titre original
Titres alternatifs
Date de première publication
Personnes ou personnages
Lieux importants
Évènements importants
Films connexes
Épigraphe
Dédicace
Premiers mots
Citations
Derniers mots
Notice de désambigüisation
Directeur de publication
Courtes éloges de critiques
Langue d'origine
DDC/MDS canonique
LCC canonique

Références à cette œuvre sur des ressources externes.

Wikipédia en anglais (2)

The average person - indeed, even the relatively sophisticated reader - is at once dazzled and mystified by the facts of biotechnology, both as a business and as an intellectual enterprise. Now Arthur Kornberg, drawing extensively on his own experiences in biotech ventures, elucidates much about this most exciting of human undertakings. In The Golden Helix, he provides an insider's view of biotechnology - an inherently fascinating confluence of science and industry made possible, in large measure, by his epoch-making work with enzymes and DNA, for which he was awarded a Nobel Prize. Although science is at the center of this story, its principal subject is people - not only research scientists but business executives and managers as well. One of the most prominent and impressive figures in the story is Alejandro Zaffaroni, a remarkably successful and charismatic scientist-entrepreneur, whose vision and enthusiasm were instrumental in the founding of the DNAX Institute of Molecular and Cellular Biology, Inc. Another remarkable character in this story is Robert P. Luciano, CEO of the Schering-Plough Corporation, the pharmaceutical company that acquired DNAX a little more than a year after its founding. Although the history of DNAX is presented here in the greatest detail, various other prominent biotech ventures are profiled as well, including, most notably, ALZA, Genentech, Amgen, Chiron, and Regeneron.

Aucune description trouvée dans une bibliothèque

Description du livre
Résumé sous forme de haïku

Discussion en cours

Aucun

Couvertures populaires

Vos raccourcis

Évaluation

Moyenne: (2.83)
0.5
1
1.5
2
2.5 1
3 2
3.5
4
4.5
5

Est-ce vous ?

Devenez un(e) auteur LibraryThing.

 

À propos | Contact | LibraryThing.com | Respect de la vie privée et règles d'utilisation | Aide/FAQ | Blog | Boutique | APIs | TinyCat | Bibliothèques historiques | Critiques en avant-première | Partage des connaissances | 205,025,358 livres! | Barre supérieure: Toujours visible